Skip to main content

Welkom bij Erasmus MC & Bohn Stafleu van Loghum

Erasmus MC heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Registreer

Om ook buiten de locaties van Erasmus MC, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van Erasmus MC.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

01-08-2005 | Perinatologie

Foetale hartritmestoornissen: recente ontwikkelingen

Auteur: Dr. M. A. Oudijk

Gepubliceerd in: Tijdschrift voor Kindergeneeskunde | Uitgave 4/2005

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Foetale hartritmestoornissen komen in een klein percentage van alle zwangerschappen voor. Brady- en tachycardieën kunnen ernstige morbiditeit en mortaliteit veroorzaken. Een vroege diagnose, begrip van de oorzaak, de mogelijke gevolgen en eventuele behandeling in utero van de hartritmestoornis zijn van belang voor een optimale aanpak. Dit artikel omschrijft de verschillende vormen van hartritmestoornissen in detail. Recente ontwikkelingen in nieuwe methoden van diagnose en nieuwe inzichten in behandeling komen aan bod.
Literatuur
go back to reference Bergmans MG, Jonker GJ, Kock HC. Fetal supraventricular tachycardia. Review of the literature. Obstet Gynecol Surv 1985;40:61-8.CrossRefPubMed Bergmans MG, Jonker GJ, Kock HC. Fetal supraventricular tachycardia. Review of the literature. Obstet Gynecol Surv 1985;40:61-8.CrossRefPubMed
go back to reference Rooth G, Huch A, Huch R. Guidelines for the use of fetal monitoring. Int J Gynecol Obstet 1987;25:159.CrossRef Rooth G, Huch A, Huch R. Guidelines for the use of fetal monitoring. Int J Gynecol Obstet 1987;25:159.CrossRef
go back to reference Nijhuis IJM, Hof J ten, Mulder EJH, et al. Antenatal fetal heart rate monitoring; normograms and minimal duration of recordings. Prenat Neonat Med 1998;3:314-22. Nijhuis IJM, Hof J ten, Mulder EJH, et al. Antenatal fetal heart rate monitoring; normograms and minimal duration of recordings. Prenat Neonat Med 1998;3:314-22.
go back to reference Kleinman CS, Nehgme R, Copel JA, et al. Fetal cardiac arrhythmias: diagnosis and therapy. In: Creasy RK, Resnik R, eds. Matern-fetal medicine. Philadelphia: Saunders, 1998. p. 301-18. Kleinman CS, Nehgme R, Copel JA, et al. Fetal cardiac arrhythmias: diagnosis and therapy. In: Creasy RK, Resnik R, eds. Matern-fetal medicine. Philadelphia: Saunders, 1998. p. 301-18.
go back to reference Quartero HW, Stinstra JG, Golbach EG, et al. Clinical implications of fetal magnetocardiography. Ultrasound Obstet Gynecol 2002;20(2):142-53.CrossRefPubMed Quartero HW, Stinstra JG, Golbach EG, et al. Clinical implications of fetal magnetocardiography. Ultrasound Obstet Gynecol 2002;20(2):142-53.CrossRefPubMed
go back to reference Fouron JC, Proulx F, Miró J, Gosselin J. Doppler and M-mode ultrasonography to time fetal atrial and ventricular contractions. Obstet Gynecol 2000;96:732-6.CrossRefPubMed Fouron JC, Proulx F, Miró J, Gosselin J. Doppler and M-mode ultrasonography to time fetal atrial and ventricular contractions. Obstet Gynecol 2000;96:732-6.CrossRefPubMed
go back to reference Fouron JC, Fournier A, Proulx F, et al. Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart 2003;89:1211-6.CrossRefPubMed Fouron JC, Fournier A, Proulx F, et al. Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart 2003;89:1211-6.CrossRefPubMed
go back to reference Guntheroth WG, Cyr DR, Shields LE, Nghiem HV. Rate-based management of fetal supraventricular tachycardia. J Ultrasound Med 1996;15:453-8.PubMed Guntheroth WG, Cyr DR, Shields LE, Nghiem HV. Rate-based management of fetal supraventricular tachycardia. J Ultrasound Med 1996;15:453-8.PubMed
go back to reference Naheed ZJ, Strasburger JF, Deal BJ, et al. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 1996;27:1736-40.CrossRefPubMed Naheed ZJ, Strasburger JF, Deal BJ, et al. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 1996;27:1736-40.CrossRefPubMed
go back to reference Sonesson SE, Winberg P, Lidegran M, Westgren M. Foetal supraventricular tachycardia and cerebral complications. Acta Paediatr 1996;85:1249-52.PubMed Sonesson SE, Winberg P, Lidegran M, Westgren M. Foetal supraventricular tachycardia and cerebral complications. Acta Paediatr 1996;85:1249-52.PubMed
go back to reference Schade RP, Stoutenbeek Ph, de Vries LS, Meijboom EJ. Neurological morbidity after fetal supraventricular tachyarrhythmia. Ultrasound Obstet Gynecol 1999;13:43-7.CrossRefPubMed Schade RP, Stoutenbeek Ph, de Vries LS, Meijboom EJ. Neurological morbidity after fetal supraventricular tachyarrhythmia. Ultrasound Obstet Gynecol 1999;13:43-7.CrossRefPubMed
go back to reference Oudijk MA, Gooskens RHJM, Stoutenbeek Ph, et al. Neurological outcome of children who were treated for fetal tachycardia complicated by hydrops. Ultrasound Obstet Gynecol 2004;24:154-8.CrossRefPubMed Oudijk MA, Gooskens RHJM, Stoutenbeek Ph, et al. Neurological outcome of children who were treated for fetal tachycardia complicated by hydrops. Ultrasound Obstet Gynecol 2004;24:154-8.CrossRefPubMed
go back to reference Gest AL, Hansen TN, Moise AA, Hartley CJ. Atrial tachycardia causes hydrops in fetal lambs. Am J Physiol 1990;258: H1159-63.PubMed Gest AL, Hansen TN, Moise AA, Hartley CJ. Atrial tachycardia causes hydrops in fetal lambs. Am J Physiol 1990;258: H1159-63.PubMed
go back to reference Wladimiroff JW, Stewart PA. Treatment of fetal cardiac arrhythmias. Br J Hosp Med 1985;34:134-40.PubMed Wladimiroff JW, Stewart PA. Treatment of fetal cardiac arrhythmias. Br J Hosp Med 1985;34:134-40.PubMed
go back to reference Jouannic JM, Le Bidois J, Fermont L, et al. Prenatal ultrasound may predict fetal response to therapy in non-hydropic fetuses with supraventricular tachycardia. Fetal Diagn Ther 2002;17:120-3.CrossRefPubMed Jouannic JM, Le Bidois J, Fermont L, et al. Prenatal ultrasound may predict fetal response to therapy in non-hydropic fetuses with supraventricular tachycardia. Fetal Diagn Ther 2002;17:120-3.CrossRefPubMed
go back to reference Oudijk MA. Fetal tachycardia, diagnosis and treatment, and the fetal QT interval in hypoxia [thesis]. Utrecht 2003. Oudijk MA. Fetal tachycardia, diagnosis and treatment, and the fetal QT interval in hypoxia [thesis]. Utrecht 2003.
go back to reference Engelen AD van, Weijtens O, Brenner JI, et al. Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994;24:1371-5.PubMed Engelen AD van, Weijtens O, Brenner JI, et al. Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994;24:1371-5.PubMed
go back to reference Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998;79:576-81.PubMed Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998;79:576-81.PubMed
go back to reference Allan LD, Chita SK, Sharland GK, et al. Flecainide in the treatment of fetal tachycardias. Br Heart J 1991;65:46-8.CrossRefPubMed Allan LD, Chita SK, Sharland GK, et al. Flecainide in the treatment of fetal tachycardias. Br Heart J 1991;65:46-8.CrossRefPubMed
go back to reference Krapp M, Baschat AA, Gembruch U, et al. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002;19:158-64.CrossRefPubMed Krapp M, Baschat AA, Gembruch U, et al. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002;19:158-64.CrossRefPubMed
go back to reference Strasburger JF, Cuneo BF, Michon MM, et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 2004;109(3):375-9.CrossRefPubMed Strasburger JF, Cuneo BF, Michon MM, et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 2004;109(3):375-9.CrossRefPubMed
go back to reference Oudijk MA, Michon MM, Kleinman CS, et al. Sotalol in the treatment of fetal dysrhythmias. Circulation 200;101:2721-6. Oudijk MA, Michon MM, Kleinman CS, et al. Sotalol in the treatment of fetal dysrhythmias. Circulation 200;101:2721-6.
go back to reference Oudijk MA, Ruskamp JM, Ververs FFT, et al. Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol 2003;42(4):765-70.CrossRefPubMed Oudijk MA, Ruskamp JM, Ververs FFT, et al. Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol 2003;42(4):765-70.CrossRefPubMed
go back to reference Anderson RH, Weninck ACG, Losekoot TG, Becker AE. Congenitally complete heart block: developmental aspects. Circulation 1977;56:90-101.PubMed Anderson RH, Weninck ACG, Losekoot TG, Becker AE. Congenitally complete heart block: developmental aspects. Circulation 1977;56:90-101.PubMed
go back to reference Chow LT, Cook AC, Ho SY, et al. Isolated congenitally complete heart block attributable to combined nodoventricular and intraventricular discontinuity. Hum Pathol 1998;29:729-36.CrossRefPubMed Chow LT, Cook AC, Ho SY, et al. Isolated congenitally complete heart block attributable to combined nodoventricular and intraventricular discontinuity. Hum Pathol 1998;29:729-36.CrossRefPubMed
go back to reference Michaelsson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 1972;4:86-101. Michaelsson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 1972;4:86-101.
go back to reference Scott JS, Maddison PJ, Taylor PV, et al. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983;309:209-12.PubMedCrossRef Scott JS, Maddison PJ, Taylor PV, et al. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983;309:209-12.PubMedCrossRef
go back to reference Ramsey-Goldman R, Hom D, Deng J-S, et al. Anti SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 1988;31:697-701.CrossRef Ramsey-Goldman R, Hom D, Deng J-S, et al. Anti SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 1988;31:697-701.CrossRef
go back to reference Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994;120:544-51.PubMed Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994;120:544-51.PubMed
go back to reference Breur JMPJ, Kapusta L, Stoutenbeek P, et al. Isolated congenital atrioventricular block diagnosed in utero: natural history and outcome. Chapter 3 in Breur JMPJ. Fetal heart block [thesis]. Utrecht, 2003. Breur JMPJ, Kapusta L, Stoutenbeek P, et al. Isolated congenital atrioventricular block diagnosed in utero: natural history and outcome. Chapter 3 in Breur JMPJ. Fetal heart block [thesis]. Utrecht, 2003.
go back to reference Udink ten Cate FEA, Breur JMPJ, Cohen MI, et al. Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. J Am Coll Cardiol 2001;37:1129-34.CrossRefPubMed Udink ten Cate FEA, Breur JMPJ, Cohen MI, et al. Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. J Am Coll Cardiol 2001;37:1129-34.CrossRefPubMed
go back to reference Buyon JP, Hiebert R, Copel JA, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.CrossRefPubMed Buyon JP, Hiebert R, Copel JA, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.CrossRefPubMed
go back to reference Jaeggi E, Hamilton RM, Silverman ED, et al. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: a single institution's experience of 30 years. J Am Coll Cardiol 2002;39:130-7.CrossRefPubMed Jaeggi E, Hamilton RM, Silverman ED, et al. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: a single institution's experience of 30 years. J Am Coll Cardiol 2002;39:130-7.CrossRefPubMed
go back to reference Eronen M, Siren MK, Ekblad H, et al. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000;106:86-91.CrossRefPubMed Eronen M, Siren MK, Ekblad H, et al. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000;106:86-91.CrossRefPubMed
go back to reference Breur JMPJ, Gooskens RHJM, Kapusta L, et al. Neurological outcome of isolated congenital heart block diagnosed in utero, complicated by hydrops. Chapter 5 in Breur JMPJ. Fetal heart block [thesis]. Utrecht, 2003. Breur JMPJ, Gooskens RHJM, Kapusta L, et al. Neurological outcome of isolated congenital heart block diagnosed in utero, complicated by hydrops. Chapter 5 in Breur JMPJ. Fetal heart block [thesis]. Utrecht, 2003.
go back to reference Kitridou RC. The neonatal lupus syndrome. In: Dubois' Lupus erythematosus. Philadelphia: Lippincott Williams & 38; Wilkins, 2002. Table 49-2. Kitridou RC. The neonatal lupus syndrome. In: Dubois' Lupus erythematosus. Philadelphia: Lippincott Williams & 38; Wilkins, 2002. Table 49-2.
go back to reference Breur JMPJ, Visser GHA, Kruize AA, et al. Treatment of fetal heart block with maternal steroid therapy: case report and review of literature. Ultrasound Obstet Gynecol 2004;24(4):467-72.CrossRefPubMed Breur JMPJ, Visser GHA, Kruize AA, et al. Treatment of fetal heart block with maternal steroid therapy: case report and review of literature. Ultrasound Obstet Gynecol 2004;24(4):467-72.CrossRefPubMed
Metagegevens
Titel
Foetale hartritmestoornissen: recente ontwikkelingen
Auteur
Dr. M. A. Oudijk
Publicatiedatum
01-08-2005
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Kindergeneeskunde / Uitgave 4/2005
Print ISSN: 0376-7442
Elektronisch ISSN: 1875-6840
DOI
https://doi.org/10.1007/BF03061557